GlaxoSmithKline agrees to $105M settlement with NH among other states

SAN DIEGO (AP) -- GlaxoSmithKline PLC will pay $105 million to dozens of states to settle allegations that it unlawfully marketed its asthma drug Advair and the antidepressants Paxil and Wellbutrin.
CLICK TO VIEW THE SOURCE MATERIAL